Bryn Mawr Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Sell |
11,271
-1,215
| -10% | -$147K | 0.07% | 179 |
|
|
2025
Q1 | $1.39M | Sell |
12,486
-398
| -3% | -$44.4K | 0.08% | 172 |
|
|
2024
Q4 | $1.25M | Buy |
12,884
+100
| +0.8% | +$9.73K | 0.07% | 191 |
|
|
2024
Q3 | $1.47M | Sell |
12,784
-211
| -2% | -$24.3K | 0.08% | 181 |
|
|
2024
Q2 | $1.38M | Buy |
12,995
+274
| +2% | +$29.2K | 0.08% | 183 |
|
|
2024
Q1 | $1.23M | Sell |
12,721
-180
| -1% | -$17.4K | 0.07% | 201 |
|
|
2023
Q4 | $1.3M | Sell |
12,901
-371
| -3% | -$37.5K | 0.08% | 191 |
|
|
2023
Q3 | $1.35M | Buy |
+13,272
| New | +$1.35M | 0.09% | 175 |
|
|
2019
Q2 | – | Sell |
-2,846
| Closed | -$245K | – | 89 |
|
|
2019
Q1 | $245K | Buy |
+2,846
| New | +$245K | 0.22% | 70 |
|